Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Altisent

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Virus Research|February 2, 2000
Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapyC Briones, A Mas, G Gómez-Mariano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy of high-temperature dry heat in inactivating parvovirusD B Rubinstein, G Flores, J C Juarez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C virusesG Flores, J C Juárez, J B Montoro, et al.
Antiviral Therapy|August 1, 1996
Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patientsR Bravo, V Soriano, J García-Samaniego, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Continuous infusion in haemophilia: current practice in EuropeA Batorova, P Holme, A Gringeri, et al.
Medicina Clinica|March 16, 1991
[The administration of factor VIII concentrates to hemophiliacs by continuous perfusion pump]S Rodríguez Bueno, J B Montoro Ronsano, B Martínez Sánchez, et al.
Blood|September 15, 1995
An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patientsJ B Montoro, J Oliveras, J I Lorenzo, et al.
American Journal of Hematology|February 1, 1994
Hemophilic pseudotumor: multicenter experience over a 25-year periodM Magallón, J Monteagudo, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2018
Moderate and severe haemophilia in Spain: An epidemiological updateJ A Aznar, C Altisent, M T Álvarez-Román, et al.
Transfusion|April 25, 2000
Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivativesJ Barretina, J Blanco, A Gutiérrez, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Virus Research|February 2, 2000
Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapyC Briones, A Mas, G Gómez-Mariano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy of high-temperature dry heat in inactivating parvovirusD B Rubinstein, G Flores, J C Juarez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C virusesG Flores, J C Juárez, J B Montoro, et al.
Antiviral Therapy|August 1, 1996
Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patientsR Bravo, V Soriano, J García-Samaniego, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Continuous infusion in haemophilia: current practice in EuropeA Batorova, P Holme, A Gringeri, et al.
Medicina Clinica|March 16, 1991
[The administration of factor VIII concentrates to hemophiliacs by continuous perfusion pump]S Rodríguez Bueno, J B Montoro Ronsano, B Martínez Sánchez, et al.
Blood|September 15, 1995
An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patientsJ B Montoro, J Oliveras, J I Lorenzo, et al.
American Journal of Hematology|February 1, 1994
Hemophilic pseudotumor: multicenter experience over a 25-year periodM Magallón, J Monteagudo, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2018
Moderate and severe haemophilia in Spain: An epidemiological updateJ A Aznar, C Altisent, M T Álvarez-Román, et al.
Transfusion|April 25, 2000
Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivativesJ Barretina, J Blanco, A Gutiérrez, et al.
Pageof 6